Efficacy and Safety Clinical Trials

8 recruiting

Efficacy and Safety Trials at a Glance

14 actively recruiting trials for efficacy and safety are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Nantong, Bois-Guillaume, and Changsha. Lead sponsors running efficacy and safety studies include Affiliated Hospital of Nantong University, Fang Wu, and Chinese PLA General Hospital.

Browse efficacy and safety trials by phase

Treatments under study

About Efficacy and Safety Clinical Trials

Looking for clinical trials for Efficacy and Safety? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Efficacy and Safety trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Efficacy and Safety clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

Efficacy of Thermal Ablation Combined With Antithyroid Drugs in the Treatment of Primary Hyperthyroidism

Efficacy and SafetyHyperthyroidism/ThyrotoxicosisComplication Rate+1 more
Chinese PLA General Hospital454 enrolled1 locationNCT07557810
Recruiting
Phase 3

A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group

Long Term Efficacy and Safety
Hansa Biopharma AB150 enrolled14 locationsNCT05937750
Recruiting

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Allergic Bronchopulmonary AspergillosisEfficacy and SafetyABPA+3 more
Qianfoshan Hospital50 enrolled1 locationNCT07362693
Recruiting
Not Applicable

Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger

Efficacy and SafetyRandomised Clinical TrialTrigger Finger+3 more
Konya Beyhekim Training and Research Hospital60 enrolled1 locationNCT07256522
Recruiting

The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)

The Efficacy and Safety of SBRT in MPLC
Fang Wu40 enrolled5 locationsNCT05113017
Recruiting
Not Applicable

Clinical Study of Fospropofol Disodium for Injection in the Painless Endoscopic Diagnosis and Treatment

Efficacy and Safety
Affiliated Hospital of Nantong University426 enrolled5 locationsNCT06732427
Recruiting
Phase 4

Clinical Studies of the Efficacy and Safety of Remimazolam for Anesthesia Induction and Maintenance in Elderly Patients

Efficacy and Safety
Affiliated Hospital of Nantong University60 enrolled1 locationNCT06690424
Recruiting
Not Applicable

Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial

SepsisEnd Stage Kidney Disease (ESRD)The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD
Navamindradhiraj University202 enrolled1 locationNCT06989892
Recruiting

Efficacy and Safety of Dalbavancin As Suppressive Therapy

Efficacy and Safety of DalbavancinIn Subjects Who Received SAT with DALFor Acute or Chronic Infections Between July 2019 and December 2024
Hospices Civils de Lyon33 enrolled1 locationNCT06899906
Recruiting

Safety and Efficacy of IMPT or IMRT for Breast Cancer

Breast CancerProton TherapyIntensity Modulated Radiation Therapy+2 more
Ruijin Hospital500 enrolled1 locationNCT06826885
Recruiting
Phase 1Phase 2

MSC Intratissular Injection in Crohn Disease Patients

Efficacy and Safety
University of Liege60 enrolled1 locationNCT03901235
Recruiting
Phase 1Phase 2

Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer

Efficacy and Safety
Xing Xie50 enrolled1 locationNCT04518501
Recruiting
Phase 2

Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer

Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer
Zhejiang Cancer Hospital20 enrolled1 locationNCT06562920
Recruiting
Phase 4

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients
The People's Hospital of Gaozhou40 enrolled1 locationNCT06365541